| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.01e-06 | 4 | 160 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 6.14e-06 | 33 | 160 | 5 | GO:0005217 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | NCAPD3 ANK2 ANK3 PRPF8 TTLL12 ATAD2B MSL3 DZIP3 KDM4A RAD23B | 6.52e-06 | 206 | 160 | 10 | GO:0140030 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 9.92e-06 | 6 | 160 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.11e-05 | 18 | 160 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 6.38e-05 | 2 | 160 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.06e-04 | 31 | 160 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.90e-04 | 40 | 160 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 3.51e-04 | 42 | 160 | 4 | GO:0071889 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.77e-04 | 18 | 160 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 3.79e-04 | 4 | 160 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | demethylase activity | 4.20e-04 | 44 | 160 | 4 | GO:0032451 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | UBA2 AK9 MSH4 FANCM DNAH7 UBA1 ATAD2B ABCC12 MYO15A DNAH6 ACSM6 DDX11L8 DYNC1H1 AQR | 4.36e-04 | 614 | 160 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 6.28e-04 | 5 | 160 | 2 | GO:0050649 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 6.28e-04 | 5 | 160 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | hypotaurine monooxygenase activity | 6.28e-04 | 5 | 160 | 2 | GO:0047822 | |
| GeneOntologyMolecularFunction | osmolarity-sensing monoatomic cation channel activity | 6.28e-04 | 5 | 160 | 2 | GO:1990760 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 6.28e-04 | 5 | 160 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 6.28e-04 | 5 | 160 | 2 | GO:0062181 | |
| GeneOntologyMolecularFunction | molecular sensor activity | 6.86e-04 | 50 | 160 | 4 | GO:0140299 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 9.35e-04 | 140 | 160 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | N,N-dimethylaniline monooxygenase activity | 9.37e-04 | 6 | 160 | 2 | GO:0004499 | |
| GeneOntologyMolecularFunction | osmosensor activity | 9.37e-04 | 6 | 160 | 2 | GO:0005034 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 9.37e-04 | 6 | 160 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 9.37e-04 | 6 | 160 | 2 | GO:0070576 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 9.79e-04 | 194 | 160 | 7 | GO:0016705 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 1.31e-03 | 7 | 160 | 2 | GO:0070643 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 1.31e-03 | 7 | 160 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.43e-03 | 28 | 160 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.52e-03 | 334 | 160 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | actin binding | FKBP15 SYNPO2 SPEF1 MYOT GBP3 LRPPRC CDK5R1 MICAL2 TLN1 PRKCE MYO15A | 1.70e-03 | 479 | 160 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 1.73e-03 | 8 | 160 | 2 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 1.73e-03 | 8 | 160 | 2 | GO:0034875 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 1.73e-03 | 8 | 160 | 2 | GO:0101021 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.83e-03 | 343 | 160 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 2.35e-03 | 115 | 160 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | spectrin binding | 2.52e-03 | 34 | 160 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 2.75e-03 | 10 | 160 | 2 | GO:0140031 | |
| GeneOntologyMolecularFunction | glycine transmembrane transporter activity | 2.75e-03 | 10 | 160 | 2 | GO:0015187 | |
| GeneOntologyMolecularFunction | ubiquitin-like modifier activating enzyme activity | 2.75e-03 | 10 | 160 | 2 | GO:0008641 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.21e-03 | 37 | 160 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | RANGAP1 MYOT ANK3 CDHR2 ADAM18 DOCK9 ARHGEF16 MMP24 CDK5R1 TLN1 PRKCA ADAM2 | 3.27e-03 | 599 | 160 | 12 | GO:0050839 |
| GeneOntologyMolecularFunction | histone H3K36 demethylase activity | 3.35e-03 | 11 | 160 | 2 | GO:0051864 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 3.35e-03 | 11 | 160 | 2 | GO:0101020 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 5.71e-05 | 88 | 159 | 6 | GO:0016529 | |
| GeneOntologyCellularComponent | Z disc | 1.59e-04 | 151 | 159 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.39e-04 | 114 | 159 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | I band | 2.85e-04 | 166 | 159 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.90e-04 | 290 | 159 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | FMO2 FMO3 CYP3A4 NOX5 DNAJC16 CYP3A43 COPB2 ELOVL1 EIF5A2 ERGIC2 RYR1 USP19 RYR2 RYR3 ITPR3 LRPPRC UBA1 SEC24C OR11A1 ABCC12 UGT3A2 ATG9A | 4.64e-04 | 1327 | 159 | 22 | GO:0042175 |
| GeneOntologyCellularComponent | Mon1-Ccz1 complex | 5.66e-04 | 5 | 159 | 2 | GO:0035658 | |
| GeneOntologyCellularComponent | costamere | 5.98e-04 | 22 | 159 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | sarcolemma | 6.40e-04 | 190 | 159 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | sarcomere | 6.55e-04 | 249 | 159 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | FMO2 FMO3 CYP3A4 NOX5 DNAJC16 CYP3A43 COPB2 ELOVL1 EIF5A2 ERGIC2 RYR1 USP19 RYR2 RYR3 ITPR3 UBA1 SEC24C OR11A1 ABCC12 UGT3A2 ATG9A | 8.20e-04 | 1293 | 159 | 21 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | FMO2 FMO3 CYP3A4 NOX5 DNAJC16 CYP3A43 COPB2 ELOVL1 EIF5A2 ERGIC2 RYR1 USP19 RYR2 RYR3 ITPR3 UBA1 SEC24C OR11A1 ABCC12 UGT3A2 ATG9A | 8.69e-04 | 1299 | 159 | 21 | GO:0098827 |
| GeneOntologyCellularComponent | myofibril | 1.19e-03 | 273 | 159 | 8 | GO:0030016 | |
| Domain | RIH_assoc-dom | 7.49e-08 | 6 | 159 | 4 | IPR013662 | |
| Domain | Ins145_P3_rec | 7.49e-08 | 6 | 159 | 4 | PF08709 | |
| Domain | RIH_assoc | 7.49e-08 | 6 | 159 | 4 | PF08454 | |
| Domain | RIH_dom | 7.49e-08 | 6 | 159 | 4 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.49e-08 | 6 | 159 | 4 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.49e-08 | 6 | 159 | 4 | IPR015925 | |
| Domain | - | 7.49e-08 | 6 | 159 | 4 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.49e-08 | 6 | 159 | 4 | PF01365 | |
| Domain | Ryanodine_rcpt | 6.05e-07 | 3 | 159 | 3 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 6.05e-07 | 3 | 159 | 3 | IPR009460 | |
| Domain | RyR | 6.05e-07 | 3 | 159 | 3 | PF02026 | |
| Domain | RR_TM4-6 | 6.05e-07 | 3 | 159 | 3 | PF06459 | |
| Domain | Ryan_recept | 6.05e-07 | 3 | 159 | 3 | IPR013333 | |
| Domain | MIR | 1.02e-06 | 10 | 159 | 4 | PF02815 | |
| Domain | MIR_motif | 1.02e-06 | 10 | 159 | 4 | IPR016093 | |
| Domain | MIR | 1.02e-06 | 10 | 159 | 4 | PS50919 | |
| Domain | MIR | 1.02e-06 | 10 | 159 | 4 | SM00472 | |
| Domain | ARM-type_fold | NCAPD3 DOCK9 INTS1 USP24 MROH5 PSMD2 RYR3 URB1 MROH8 NF1 XPO5 AGBL1 | 3.45e-05 | 339 | 159 | 12 | IPR016024 |
| Domain | Ion_trans_dom | 5.45e-05 | 114 | 159 | 7 | IPR005821 | |
| Domain | Ion_trans | 5.45e-05 | 114 | 159 | 7 | PF00520 | |
| Domain | DUF1712 | 7.20e-05 | 2 | 159 | 2 | PF08217 | |
| Domain | DUF1712_fun | 7.20e-05 | 2 | 159 | 2 | IPR013176 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.06e-04 | 14 | 159 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.06e-04 | 14 | 159 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.06e-04 | 14 | 159 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.06e-04 | 14 | 159 | 3 | PF08393 | |
| Domain | MT | 2.06e-04 | 14 | 159 | 3 | PF12777 | |
| Domain | AAA_8 | 2.06e-04 | 14 | 159 | 3 | PF12780 | |
| Domain | Amyloid_glyco_E2_domain | 2.15e-04 | 3 | 159 | 2 | IPR024329 | |
| Domain | A4_EXTRA | 2.15e-04 | 3 | 159 | 2 | PS00319 | |
| Domain | Amyloid_glyco_heparin-bd | 2.15e-04 | 3 | 159 | 2 | IPR015849 | |
| Domain | A4_INTRA | 2.15e-04 | 3 | 159 | 2 | PS00320 | |
| Domain | - | 2.15e-04 | 3 | 159 | 2 | 3.90.570.10 | |
| Domain | APP_N | 2.15e-04 | 3 | 159 | 2 | PF02177 | |
| Domain | APP_Cu_bd | 2.15e-04 | 3 | 159 | 2 | PF12924 | |
| Domain | APP_E2 | 2.15e-04 | 3 | 159 | 2 | PF12925 | |
| Domain | APP_amyloid | 2.15e-04 | 3 | 159 | 2 | PF10515 | |
| Domain | Amyloid_glyco | 2.15e-04 | 3 | 159 | 2 | IPR008155 | |
| Domain | Amyloid_glyco_extra | 2.15e-04 | 3 | 159 | 2 | IPR008154 | |
| Domain | - | 2.15e-04 | 3 | 159 | 2 | 3.30.1490.140 | |
| Domain | APP_amyloid_C | 2.15e-04 | 3 | 159 | 2 | IPR019543 | |
| Domain | Amyloid_glyco_extracell_CS | 2.15e-04 | 3 | 159 | 2 | IPR019744 | |
| Domain | Amyloid_glyco_intracell_CS | 2.15e-04 | 3 | 159 | 2 | IPR019745 | |
| Domain | Amyloid_glyco_Cu-bd | 2.15e-04 | 3 | 159 | 2 | IPR011178 | |
| Domain | A4_EXTRA | 2.15e-04 | 3 | 159 | 2 | SM00006 | |
| Domain | DHC_fam | 2.56e-04 | 15 | 159 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.56e-04 | 15 | 159 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.56e-04 | 15 | 159 | 3 | IPR004273 | |
| Domain | UBQ-activ_enz_E1_CS | 4.27e-04 | 4 | 159 | 2 | IPR018074 | |
| Domain | PPR | 4.27e-04 | 4 | 159 | 2 | PF01535 | |
| Domain | Gal_mutarotase_N | 4.27e-04 | 4 | 159 | 2 | IPR031727 | |
| Domain | - | 4.27e-04 | 4 | 159 | 2 | 1.10.3240.10 | |
| Domain | UBQ-activ_enz_E1_Cys_AS | 4.27e-04 | 4 | 159 | 2 | IPR033127 | |
| Domain | NtCtMGAM_N | 4.27e-04 | 4 | 159 | 2 | PF16863 | |
| Domain | UBIQUITIN_ACTIVAT_1 | 7.08e-04 | 5 | 159 | 2 | PS00536 | |
| Domain | Flavin_mOase | 7.08e-04 | 5 | 159 | 2 | IPR000960 | |
| Domain | UBA_E1_Cys | 7.08e-04 | 5 | 159 | 2 | IPR019572 | |
| Domain | DiMe-aniline_mOase | 7.08e-04 | 5 | 159 | 2 | IPR012143 | |
| Domain | FMO-like | 7.08e-04 | 5 | 159 | 2 | PF00743 | |
| Domain | Cyt_P450_E_grp-II | 7.08e-04 | 5 | 159 | 2 | IPR002402 | |
| Domain | UBIQUITIN_ACTIVAT_2 | 7.08e-04 | 5 | 159 | 2 | PS00865 | |
| Domain | UBA_e1_thiolCys | 7.08e-04 | 5 | 159 | 2 | PF10585 | |
| Domain | Flavin_mOase-like | 7.08e-04 | 5 | 159 | 2 | IPR020946 | |
| Domain | Cyt_P450_E_CYP3A | 1.06e-03 | 6 | 159 | 2 | IPR008072 | |
| Domain | Glyco_hydro_31_AS | 1.06e-03 | 6 | 159 | 2 | IPR030458 | |
| Domain | UBQ/SUMO-activ_enz_E1-like | 1.06e-03 | 6 | 159 | 2 | IPR000011 | |
| Domain | AAA | 1.47e-03 | 144 | 159 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.47e-03 | 144 | 159 | 6 | IPR003593 | |
| Domain | Glyco_hydro_31 | 1.47e-03 | 7 | 159 | 2 | IPR000322 | |
| Domain | Glyco_hydro_31 | 1.47e-03 | 7 | 159 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 1.47e-03 | 7 | 159 | 2 | PS00129 | |
| Domain | - | SAMD9 CHST6 GBP3 AK9 MSH4 FANCM DNAH7 GTPBP2 SAMD9L ATAD2B ABCC12 MYO15A DNAH6 DYNC1H1 AQR | 1.80e-03 | 746 | 159 | 15 | 3.40.50.300 |
| Domain | PPR | 1.95e-03 | 8 | 159 | 2 | PS51375 | |
| Domain | Trefoil | 1.95e-03 | 8 | 159 | 2 | PF00088 | |
| Domain | P_TREFOIL_2 | 2.49e-03 | 9 | 159 | 2 | PS51448 | |
| Domain | ZU5 | 2.49e-03 | 9 | 159 | 2 | SM00218 | |
| Domain | PD | 2.49e-03 | 9 | 159 | 2 | SM00018 | |
| Domain | ThiF_NAD_FAD-bd | 3.10e-03 | 10 | 159 | 2 | IPR000594 | |
| Domain | ThiF | 3.10e-03 | 10 | 159 | 2 | PF00899 | |
| Domain | ZU5 | 3.10e-03 | 10 | 159 | 2 | PS51145 | |
| Domain | - | 3.77e-03 | 11 | 159 | 2 | 4.10.110.10 | |
| Domain | Pkinase_C | 3.80e-03 | 37 | 159 | 3 | IPR017892 | |
| Domain | P_trefoil_dom | 4.49e-03 | 12 | 159 | 2 | IPR000519 | |
| Domain | ZU5 | 4.49e-03 | 12 | 159 | 2 | PF00791 | |
| Domain | ZU5_dom | 4.49e-03 | 12 | 159 | 2 | IPR000906 | |
| Domain | Pkinase_C | 5.45e-03 | 42 | 159 | 3 | PF00433 | |
| Domain | P-loop_NTPase | SAMD9 CHST6 GBP3 AK9 MSH4 FANCM DNAH7 GTPBP2 SAMD9L ATAD2B ABCC12 MYO15A DNAH6 DYNC1H1 AQR | 5.93e-03 | 848 | 159 | 15 | IPR027417 |
| Domain | G-protein_beta_WD-40_rep | 6.00e-03 | 85 | 159 | 4 | IPR020472 | |
| Domain | ATPase_dyneun-rel_AAA | 6.13e-03 | 14 | 159 | 2 | IPR011704 | |
| Domain | AAA_5 | 6.13e-03 | 14 | 159 | 2 | PF07728 | |
| Domain | UBA | 6.21e-03 | 44 | 159 | 3 | IPR015940 | |
| Domain | UBA | 7.46e-03 | 47 | 159 | 3 | PS50030 | |
| Domain | Disintegrin_CS | 7.99e-03 | 16 | 159 | 2 | IPR018358 | |
| Domain | ARM-like | 8.48e-03 | 270 | 159 | 7 | IPR011989 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.19e-05 | 19 | 127 | 4 | M47760 | |
| Pubmed | RANGAP1 POLE COPB2 INTS1 USP24 PSMD2 OAT PRPF8 ITPR3 TTLL12 LRPPRC URB1 NF1 SEC24C XPO5 CSNK2A2 TLN1 ATAD2B PWP2 DYNC1H1 AQR | 3.41e-12 | 653 | 160 | 21 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NCAPD3 RANGAP1 DENND4A MARS1 POLE COPB2 PSMD2 APLP2 OAT CMYA5 PRPF8 USP19 TTLL12 LRPPRC URB1 UBA1 MROH8 NF1 XPO5 CSNK2A2 TLN1 MIF PWP2 DYNC1H1 AQR MGAM2 RAD23B | 4.15e-10 | 1425 | 160 | 27 | 30948266 |
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 2.15e-09 | 5 | 160 | 4 | 19011160 | |
| Pubmed | 2.15e-09 | 5 | 160 | 4 | 25950943 | ||
| Pubmed | 6.42e-09 | 6 | 160 | 4 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 6.42e-09 | 6 | 160 | 4 | 25966694 | |
| Pubmed | 6.42e-09 | 6 | 160 | 4 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 6.42e-09 | 6 | 160 | 4 | 16844763 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CCZ1B RANGAP1 POLE COPB2 INTS1 USP24 PSMD2 PRPF8 NF1 SEC24C XPO5 CCZ1 TLN1 RBM7 DYNC1H1 AQR | 1.36e-08 | 582 | 160 | 16 | 20467437 |
| Pubmed | 1.49e-08 | 7 | 160 | 4 | 11860456 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 2.98e-08 | 8 | 160 | 4 | 19033399 | |
| Pubmed | RANGAP1 MARS1 DNAJC16 COPB2 USP24 PSMD2 PRPF8 USP19 TTLL12 LRPPRC UBA1 SEC24C XPO5 TLN1 PWP2 DYNC1H1 | 4.84e-08 | 638 | 160 | 16 | 33239621 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 18403125 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 7876312 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 9.56e-08 | 3 | 160 | 3 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 9.56e-08 | 3 | 160 | 3 | 7621815 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 9.56e-08 | 3 | 160 | 3 | 10473538 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 9.56e-08 | 3 | 160 | 3 | 9204703 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 9.56e-08 | 3 | 160 | 3 | 12213830 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 9242641 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 25239916 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 18643873 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 11159936 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 9.56e-08 | 3 | 160 | 3 | 4600883 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 7635066 | ||
| Pubmed | RANGAP1 ANK2 ANK3 MARS1 CARMIL1 COPB2 USP24 PSMD2 KEAP1 LRPPRC UBA1 LATS1 SEC24C XPO5 TLN1 DYNC1H1 | 1.98e-07 | 708 | 160 | 16 | 39231216 | |
| Pubmed | 2.51e-07 | 30 | 160 | 5 | 20529763 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANGAP1 MARS1 POLE TAF1B COPB2 ADNP2 PSMD2 PRPF8 BLVRA LRPPRC URB1 UBA1 NF1 SEC24C MICAL2 TLN1 MIF RBM7 PRKCA KDM2A DYNC1H1 AQR | 2.90e-07 | 1353 | 160 | 22 | 29467282 |
| Pubmed | CES1 ADAM18 USP24 KEAP1 MMP24 NEK1 BMPR1A UBA1 LATS1 CSNK2A2 SEMA3B PRKCA PRKCE PPIL2 KDM2A ADAM2 | 2.98e-07 | 730 | 160 | 16 | 34857952 | |
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 22100703 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 3.81e-07 | 4 | 160 | 3 | 23413940 | |
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 9607712 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 23482488 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 18206662 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 9384575 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCAPD3 RANGAP1 MARS1 DNAJC16 POLE COPB2 USP24 PSMD2 APLP2 USP19 ITPR3 TTLL12 LRPPRC URB1 XPO5 TLN1 PPIL2 DYNC1H1 | 3.89e-07 | 942 | 160 | 18 | 31073040 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | NCAPD3 RANGAP1 MARS1 COPB2 UBA2 PRPF8 TTLL12 UBA1 XPO5 TLN1 DYNC1H1 | 4.46e-07 | 332 | 160 | 11 | 32786267 |
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 18550753 | ||
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 23918386 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 1.89e-06 | 6 | 160 | 3 | 26025922 | |
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 1.89e-06 | 6 | 160 | 3 | 14592808 | |
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 19009018 | ||
| Pubmed | ANK2 ANK3 MARS1 CARMIL1 COPB2 EIF5A2 PSMD2 OAT RUFY3 LRPPRC UBA1 NF1 SEC24C MICAL2 CSNK2A2 NMT2 TLN1 PRKCA PRKCE DNAH6 DYNC1H1 | 2.81e-06 | 1431 | 160 | 21 | 37142655 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FKBP15 NCAPD3 DNAJC16 POLE COPB2 UBA2 PSMD2 APLP2 OAT PRPF8 ITPR3 LRPPRC XPO5 CSNK2A2 LPP SNX8 RAD23B | 2.83e-06 | 974 | 160 | 17 | 28675297 |
| Pubmed | FKBP15 DNAJC16 DOCK9 SPATA2 USP19 SEC24C XPO5 TLN1 DZIP3 DYNC1H1 AQR | 3.22e-06 | 407 | 160 | 11 | 12693553 | |
| Pubmed | RANGAP1 MARS1 COPB2 USP24 UBA2 PSMD2 OAT PRPF8 USP19 LRPPRC UBA1 SEC24C XPO5 TLN1 MIF DYNC1H1 | 3.28e-06 | 878 | 160 | 16 | 37223481 | |
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 20962236 | ||
| Pubmed | RANGAP1 PDE7A ANK2 ANK3 DNAJC16 POLE OAT SPG11 DZIP1 PRPF8 BRAP ITPR3 TTLL12 LRPPRC URB1 SEC24C TLN1 PWP2 AKAP11 SEMA6A AQR | 5.09e-06 | 1487 | 160 | 21 | 33957083 | |
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 11784029 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANGAP1 MARS1 INTS1 PSMD2 PRPF8 ITPR3 LRPPRC URB1 UBA1 NF1 SEC24C TLN1 MIF PWP2 PRKCA DYNC1H1 AQR | 5.48e-06 | 1024 | 160 | 17 | 24711643 |
| Pubmed | FKBP15 RANGAP1 ANK2 ANK3 PDK2 DNAJC16 DOCK9 COPB2 USP24 PSMD2 OAT RYR2 RUFY3 LRPPRC UBA1 NF1 MIF PRKCA | 5.63e-06 | 1139 | 160 | 18 | 36417873 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | FZD3 PRPF8 TULP3 BMPR1A CSNK2A2 DZIP3 PRKCA SEMA6A DYNC1H1 PROX1 | 6.84e-06 | 358 | 160 | 10 | 32460013 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAT4 RANGAP1 COPB2 INTS1 PRPF8 RYR1 TTLL12 URB1 SAMD9L MROH8 TLN1 ATAD2B CFAP57 DYNC1H1 | 8.58e-06 | 736 | 160 | 14 | 29676528 |
| Pubmed | RANGAP1 ANK3 USP24 KEAP1 BRAP NEK1 UBA1 LATS1 TLN1 LPP KDM2A DYNC1H1 | 9.87e-06 | 549 | 160 | 12 | 38280479 | |
| Pubmed | 1.04e-05 | 225 | 160 | 8 | 12168954 | ||
| Pubmed | FKBP15 RANGAP1 ANK2 ANK3 HCN3 KEAP1 LRPPRC UBA1 NF1 SEC24C CSNK2A2 DZIP3 PRKCA PRKCE DYNC1H1 PROX1 | 1.04e-05 | 963 | 160 | 16 | 28671696 | |
| Pubmed | NCAPD3 DENND4A SAMD9 DNAJC16 POLE ELOVL1 ERGIC2 FAM111B TTLL12 GTPBP2 RHPN2 DDX11L8 AQR | 1.07e-05 | 650 | 160 | 13 | 38777146 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A CARMIL1 DZIP1 ARHGEF16 DNAH7 TTLL12 NEK1 LRPPRC LATS1 NF1 LPP RBM7 PRKCE AKAP11 AQR | 1.15e-05 | 861 | 160 | 15 | 36931259 |
| Pubmed | RANGAP1 MARS1 DNAJC16 COPB2 PSMD2 APLP2 ERGIC2 PRPF8 LRPPRC NF1 XPO5 ATG9A RAD23B | 1.20e-05 | 657 | 160 | 13 | 36180527 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ANK2 DNAJC16 CARMIL1 DOCK9 APLP2 ARHGEF16 TULP3 NF1 RHPN2 MICAL2 SEMA6A SLITRK6 | 1.41e-05 | 569 | 160 | 12 | 30639242 |
| Pubmed | USP24 PSMD2 APLP2 KEAP1 ERGIC2 SPATA2 USP19 BRAP ITPR3 UBA1 RAD23B | 1.54e-05 | 481 | 160 | 11 | 28190767 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 1.86e-05 | 118 | 160 | 6 | 27377895 | |
| Pubmed | RANGAP1 MARS1 COPB2 PSMD2 OAT PRPF8 BRAP ITPR3 LRPPRC BMPR1A LATS1 SEC24C MICAL2 TLN1 PPIL2 DYNC1H1 AQR RAD23B | 1.90e-05 | 1247 | 160 | 18 | 27684187 | |
| Pubmed | FKBP15 POLE COPB2 INTS1 UBA2 PRPF8 BLVRA UBA1 RBM12 XPO5 CSNK2A2 PWP2 KDM2A MYO15A AQR RAD23B | 1.96e-05 | 1014 | 160 | 16 | 32416067 | |
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 19095005 | ||
| Pubmed | DENND4A MYOT ANK2 DOCK9 DZIP1 CMYA5 RYR1 TULP3 LRPPRC TLN1 KDM2A | 2.09e-05 | 497 | 160 | 11 | 23414517 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20715157 | ||
| Pubmed | Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes. | 2.10e-05 | 2 | 160 | 2 | 30322869 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19655190 | ||
| Pubmed | CK2.1, a novel peptide, induces articular cartilage formation in vivo. | 2.10e-05 | 2 | 160 | 2 | 27312334 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23583712 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9489997 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 17259277 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 2.10e-05 | 2 | 160 | 2 | 12640042 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 2.10e-05 | 2 | 160 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 2.10e-05 | 2 | 160 | 2 | 26009179 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 32899693 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 14592949 | ||
| Pubmed | SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies. | 2.10e-05 | 2 | 160 | 2 | 29535429 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 8898078 | ||
| Pubmed | Deletion of inositol polyphosphate 4-phosphatase type-II B affects spermatogenesis in mice. | 2.10e-05 | 2 | 160 | 2 | 32413098 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 34621053 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9535877 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 18586264 | ||
| Pubmed | Structural aspects and physiological consequences of APP/APLP trans-dimerization. | 2.10e-05 | 2 | 160 | 2 | 21952790 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 33731850 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24505490 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 14597230 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 14550562 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9799464 | ||
| Pubmed | [Pancytopenia in children caused by SAMD9/9L mutation: 5 cases report and literature review]. | 2.10e-05 | 2 | 160 | 2 | 37357006 | |
| Pubmed | Metabolism and disposition of the dipeptidyl peptidase IV inhibitor teneligliptin in humans. | 2.10e-05 | 2 | 160 | 2 | 23855261 | |
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 2.10e-05 | 2 | 160 | 2 | 15033925 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 29447249 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 2.10e-05 | 2 | 160 | 2 | 17118445 | |
| Interaction | SIRT7 interactions | RANGAP1 POLE COPB2 INTS1 USP24 PSMD2 OAT PRPF8 ITPR3 TTLL12 LRPPRC URB1 NF1 SEC24C XPO5 CSNK2A2 TLN1 ATAD2B PWP2 DYNC1H1 AQR | 2.76e-07 | 744 | 155 | 21 | int:SIRT7 |
| Interaction | RMC1 interactions | 2.74e-06 | 152 | 155 | 9 | int:RMC1 | |
| Interaction | OPTN interactions | EIF5A2 OAT DZIP1 KEAP1 CMYA5 PRPF8 TTLL12 RBM12 SEC24C CSNK2A2 MIF ATG9A DYNC1H1 RAD23B | 4.98e-06 | 422 | 155 | 14 | int:OPTN |
| Interaction | SH2D3C interactions | 7.54e-06 | 172 | 155 | 9 | int:SH2D3C | |
| Interaction | NCF1 interactions | 1.07e-05 | 98 | 155 | 7 | int:NCF1 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.90e-07 | 3 | 105 | 3 | 287 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.57e-04 | 181 | 105 | 6 | 694 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 7.60e-04 | 31 | 105 | 3 | 81 | |
| GeneFamily | Cytochrome P450 family 3 | 9.14e-04 | 8 | 105 | 2 | 1002 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 1.46e-03 | 10 | 105 | 2 | 100 | |
| GeneFamily | C2 domain containing protein kinases | 1.46e-03 | 10 | 105 | 2 | 835 | |
| GeneFamily | Maestro heat like repeat containing | 1.78e-03 | 11 | 105 | 2 | 636 | |
| GeneFamily | Dyneins, axonemal | 4.29e-03 | 17 | 105 | 2 | 536 | |
| GeneFamily | Cadherin related | 4.29e-03 | 17 | 105 | 2 | 24 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 5.93e-03 | 20 | 105 | 2 | 736 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN | 3.88e-06 | 200 | 159 | 9 | M9637 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.48e-05 | 180 | 159 | 8 | M8239 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-07 | 184 | 160 | 8 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-07 | 193 | 160 | 8 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.07e-07 | 193 | 160 | 8 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.48e-07 | 195 | 160 | 8 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.48e-07 | 195 | 160 | 8 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.48e-07 | 195 | 160 | 8 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.51e-06 | 176 | 160 | 7 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.64e-06 | 177 | 160 | 7 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.78e-06 | 178 | 160 | 7 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.37e-06 | 182 | 160 | 7 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 4.70e-06 | 184 | 160 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.87e-06 | 185 | 160 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 5.60e-06 | 189 | 160 | 7 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.80e-06 | 190 | 160 | 7 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.21e-06 | 192 | 160 | 7 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 6.21e-06 | 192 | 160 | 7 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | COVID-19_Moderate-CD4+_T_activated|World / disease group, cell group and cell class | 6.43e-06 | 193 | 160 | 7 | c2a2a2c14a7085690262db5c2a70e38db67dee18 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.43e-06 | 193 | 160 | 7 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.43e-06 | 193 | 160 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 6.43e-06 | 193 | 160 | 7 | aa3acc7571405169efb656d214f3a8cbf988362e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.65e-06 | 194 | 160 | 7 | 3cd90d01ed5a5ce65aad8284dab2537ec16e3d7c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.87e-06 | 195 | 160 | 7 | db4270c135c392ed443670981656e3cd5b95939d | |
| ToppCell | 18-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 6.87e-06 | 195 | 160 | 7 | 3441381759cd00d125752401dc99b78be1c78f88 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.87e-06 | 195 | 160 | 7 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.87e-06 | 195 | 160 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.87e-06 | 195 | 160 | 7 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 7.35e-06 | 197 | 160 | 7 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | C_01|World / shred on cell type and cluster | 7.59e-06 | 198 | 160 | 7 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.11e-06 | 200 | 160 | 7 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 8.11e-06 | 200 | 160 | 7 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.11e-06 | 200 | 160 | 7 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.11e-06 | 200 | 160 | 7 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_T_naive|Influenza_Severe / Disease, condition lineage and cell class | 8.11e-06 | 200 | 160 | 7 | 0382f8fc27d18003761725e714beb6b3f3150057 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.11e-06 | 200 | 160 | 7 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | Influenza_Severe-CD4+_T_naive|Influenza_Severe / Disease group and Cell class | 2.23e-05 | 157 | 160 | 6 | 287bdc4e455cd0160261a93d13538e0def49fcd4 | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.76e-05 | 163 | 160 | 6 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | Ciliated_cells-A-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.95e-05 | 165 | 160 | 6 | 0ebdbbdb151fb797335013d5838af1c7bbc45b06 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 167 | 160 | 6 | 40d102e01ccbc7262d00fafd59ca5234909009cb | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-05 | 169 | 160 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-05 | 169 | 160 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 3.85e-05 | 173 | 160 | 6 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 3.98e-05 | 174 | 160 | 6 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.24e-05 | 176 | 160 | 6 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.51e-05 | 178 | 160 | 6 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 4.51e-05 | 178 | 160 | 6 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.51e-05 | 178 | 160 | 6 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.66e-05 | 179 | 160 | 6 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.95e-05 | 181 | 160 | 6 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-05 | 182 | 160 | 6 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.11e-05 | 182 | 160 | 6 | 975f6275777fc578eba528e50f69891c66ec44ad | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.11e-05 | 182 | 160 | 6 | f8c28fa76751062c4cfba0db8af1b377f947f739 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.26e-05 | 183 | 160 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.43e-05 | 184 | 160 | 6 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.76e-05 | 186 | 160 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.76e-05 | 186 | 160 | 6 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-05 | 188 | 160 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-05 | 188 | 160 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-05 | 188 | 160 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 6.11e-05 | 188 | 160 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-05 | 188 | 160 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 6.11e-05 | 188 | 160 | 6 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.23e-05 | 116 | 160 | 5 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 6.29e-05 | 189 | 160 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.29e-05 | 189 | 160 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 190 | 160 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.48e-05 | 190 | 160 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.48e-05 | 190 | 160 | 6 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.48e-05 | 190 | 160 | 6 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 190 | 160 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.48e-05 | 190 | 160 | 6 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 6.48e-05 | 190 | 160 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.67e-05 | 191 | 160 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.67e-05 | 191 | 160 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 6.67e-05 | 191 | 160 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.67e-05 | 191 | 160 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 6.67e-05 | 191 | 160 | 6 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.67e-05 | 191 | 160 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.67e-05 | 191 | 160 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.67e-05 | 191 | 160 | 6 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.67e-05 | 191 | 160 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.67e-05 | 191 | 160 | 6 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.67e-05 | 191 | 160 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.67e-05 | 191 | 160 | 6 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 6.67e-05 | 191 | 160 | 6 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.67e-05 | 191 | 160 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 6.87e-05 | 192 | 160 | 6 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 6.87e-05 | 192 | 160 | 6 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 6.87e-05 | 192 | 160 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.87e-05 | 192 | 160 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | COVID-19_Moderate-CD4+_T_activated|COVID-19_Moderate / disease group, cell group and cell class | 6.87e-05 | 192 | 160 | 6 | 7a81652406332afd03a9b3b529e9b5e6c0b54c28 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 6.87e-05 | 192 | 160 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.87e-05 | 192 | 160 | 6 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-05 | 192 | 160 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.07e-05 | 193 | 160 | 6 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.07e-05 | 193 | 160 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | LAM-Epithelial-AirwayEpi|Epithelial / Condition, Lineage and Cell class | 7.07e-05 | 193 | 160 | 6 | f2672d2c495ee12c3b7d132452bde581fa5a7856 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.07e-05 | 193 | 160 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.27e-05 | 194 | 160 | 6 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 194 | 160 | 6 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.27e-05 | 194 | 160 | 6 | 0b0042b6a356a49a059fb64a1e1abb25c82d48cf | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 7.30e-08 | 7 | 156 | 4 | CID009547999 | |
| Drug | Br2BAPTA | 7.30e-08 | 7 | 156 | 4 | CID003081001 | |
| Drug | fura 2 | 3.09e-07 | 65 | 156 | 7 | CID000057054 | |
| Drug | cis-diammineplatinum(II | 3.16e-07 | 3 | 156 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 3.16e-07 | 3 | 156 | 3 | CID002750949 | |
| Drug | 8N3-cADPR | 3.16e-07 | 3 | 156 | 3 | CID000127713 | |
| Drug | aminodantrolene | 3.16e-07 | 3 | 156 | 3 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 3.16e-07 | 3 | 156 | 3 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 3.16e-07 | 3 | 156 | 3 | CID005748312 | |
| Drug | loperamide | 6.45e-07 | 105 | 156 | 8 | CID000003954 | |
| Drug | R 478 | 6.74e-07 | 11 | 156 | 4 | CID000084223 | |
| Drug | 8-amino-cADPR | 6.74e-07 | 11 | 156 | 4 | CID003081323 | |
| Drug | Bay K 8644 | 9.62e-07 | 150 | 156 | 9 | CID000002303 | |
| Drug | PCB74 | 1.26e-06 | 4 | 156 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 1.26e-06 | 4 | 156 | 3 | CID006444275 | |
| Drug | SC 38249 | 1.26e-06 | 4 | 156 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 1.26e-06 | 4 | 156 | 3 | CID000035682 | |
| Drug | NSC299933 | 1.45e-06 | 13 | 156 | 4 | CID000431902 | |
| Drug | 2,4-xylidinothiazoline | 1.76e-06 | 30 | 156 | 5 | CID000099296 | |
| Drug | M3/M4 | 2.46e-06 | 32 | 156 | 5 | CID000486507 | |
| Drug | Gvapspat amide | 2.73e-06 | 15 | 156 | 4 | CID000125015 | |
| Drug | kazinol B | 4.71e-06 | 17 | 156 | 4 | CID000480869 | |
| Drug | mag-fura-2 | 5.17e-06 | 37 | 156 | 5 | CID000123839 | |
| Drug | AC1L98DX | 5.92e-06 | 38 | 156 | 5 | CID000439957 | |
| Drug | chloro-m-cresol | 6.22e-06 | 6 | 156 | 3 | CID000012008 | |
| Drug | MBED | 6.22e-06 | 6 | 156 | 3 | CID000129958 | |
| Drug | AC1O528X | 6.22e-06 | 6 | 156 | 3 | CID006475857 | |
| Drug | NSC114784 | 6.22e-06 | 6 | 156 | 3 | CID000419425 | |
| Drug | strontium | 7.24e-06 | 68 | 156 | 6 | CID000104798 | |
| Drug | AC1L380G | 7.59e-06 | 19 | 156 | 4 | CID000084698 | |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | RANGAP1 C6orf62 KEAP1 SPATA2 TULP3 BRAP ATAD2B SLC25A38 KDM4A | 7.65e-06 | 193 | 156 | 9 | 7084_DN |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 9.03e-06 | 197 | 156 | 9 | 6274_UP | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 9.03e-06 | 197 | 156 | 9 | 7093_UP | |
| Drug | lead compounds | 9.37e-06 | 150 | 156 | 8 | CID000073212 | |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; PC3; HT_HG-U133A | 9.79e-06 | 199 | 156 | 9 | 5784_DN | |
| Drug | Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A | 1.02e-05 | 200 | 156 | 9 | 7480_UP | |
| Drug | Azumoleno | 1.08e-05 | 7 | 156 | 3 | CID000056259 | |
| Drug | mag-indo-1 | 1.08e-05 | 7 | 156 | 3 | CID000131881 | |
| Drug | procaine | 1.08e-05 | 153 | 156 | 8 | CID000004914 | |
| Drug | lindane | 1.14e-05 | 154 | 156 | 8 | CID000000727 | |
| Drug | 4,4'-dithiodipyridine | 1.39e-05 | 45 | 156 | 5 | CID000075846 | |
| Drug | lidocaine | 1.50e-05 | 160 | 156 | 8 | CID000003676 | |
| Drug | Fura-2AM | 1.73e-05 | 79 | 156 | 6 | CID000105091 | |
| Drug | T0702 | 2.40e-05 | 25 | 156 | 4 | CID000005908 | |
| Drug | bepridil | 2.64e-05 | 126 | 156 | 7 | CID000002351 | |
| Drug | PCB 95 | 3.66e-05 | 10 | 156 | 3 | CID000038012 | |
| Drug | valinomycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 4.25e-05 | 185 | 156 | 8 | 5906_UP | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 4.66e-05 | 2 | 156 | 2 | ctd:C005147 | |
| Drug | PCB 66 | 5.00e-05 | 11 | 156 | 3 | CID000036185 | |
| Drug | nilvadipine | 5.71e-05 | 60 | 156 | 5 | CID000004494 | |
| Drug | Trichlorfon [52-68-6]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 5.74e-05 | 193 | 156 | 8 | 5989_DN | |
| Drug | dihydropyridine | 5.74e-05 | 193 | 156 | 8 | CID000104822 | |
| Drug | Glycopyrrolate [596-51-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.95e-05 | 194 | 156 | 8 | 4709_UP | |
| Drug | Prednisone [53-03-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 6.17e-05 | 195 | 156 | 8 | 1478_DN | |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 6.17e-05 | 195 | 156 | 8 | 3295_DN | |
| Drug | indo-1 | 6.23e-05 | 99 | 156 | 6 | CID000105060 | |
| Drug | Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; PC3; HT_HG-U133A | 6.39e-05 | 196 | 156 | 8 | 4497_DN | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; PC3; HT_HG-U133A | 6.39e-05 | 196 | 156 | 8 | 5769_UP | |
| Drug | clozapine; Up 200; 10uM; MCF7; HT_HG-U133A | 6.39e-05 | 196 | 156 | 8 | 5226_UP | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 6.39e-05 | 196 | 156 | 8 | 3329_DN | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A | 6.39e-05 | 196 | 156 | 8 | 6101_UP | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 6.39e-05 | 196 | 156 | 8 | 7010_UP | |
| Drug | nimodipine | 6.49e-05 | 145 | 156 | 7 | CID000004497 | |
| Drug | isradipine | 6.59e-05 | 100 | 156 | 6 | CID000003784 | |
| Drug | Tiletamine hydrochloride; Up 200; 15.4uM; MCF7; HT_HG-U133A | 6.63e-05 | 197 | 156 | 8 | 6516_UP | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; HL60; HG-U133A | 6.63e-05 | 197 | 156 | 8 | 1385_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; PC3; HT_HG-U133A | 6.63e-05 | 197 | 156 | 8 | 5770_DN | |
| Drug | valdecoxib; Down 200; 10uM; PC3; HT_HG-U133A | 6.63e-05 | 197 | 156 | 8 | 6408_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 6.63e-05 | 197 | 156 | 8 | 1541_DN | |
| Drug | Ryanodine | 6.63e-05 | 12 | 156 | 3 | ctd:D012433 | |
| Drug | nonivamide | 6.63e-05 | 12 | 156 | 3 | CID000002998 | |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 6.87e-05 | 198 | 156 | 8 | 6473_DN | |
| Drug | Probenecid [57-66-9]; Down 200; 14uM; PC3; HT_HG-U133A | 6.87e-05 | 198 | 156 | 8 | 4185_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; MCF7; HT_HG-U133A | 6.87e-05 | 198 | 156 | 8 | 3944_DN | |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 6.87e-05 | 198 | 156 | 8 | 3281_DN | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; HL60; HT_HG-U133A | 6.87e-05 | 198 | 156 | 8 | 2542_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A | 6.87e-05 | 198 | 156 | 8 | 1184_DN | |
| Drug | STOCK1N-35696; Down 200; 15uM; PC3; HT_HG-U133A | 6.87e-05 | 198 | 156 | 8 | 6564_DN | |
| Drug | Fendiline hydrochloride [13636-18-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.87e-05 | 198 | 156 | 8 | 3190_DN | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; MCF7; HT_HG-U133A | 7.11e-05 | 199 | 156 | 8 | 6491_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; PC3; HT_HG-U133A | 7.11e-05 | 199 | 156 | 8 | 7318_DN | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A | 7.11e-05 | 199 | 156 | 8 | 5804_DN | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; PC3; HT_HG-U133A | 7.11e-05 | 199 | 156 | 8 | 4571_UP | |
| Drug | lercanidipine | 7.22e-05 | 63 | 156 | 5 | CID000065866 | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 7.37e-05 | 200 | 156 | 8 | 3442_DN | |
| Drug | CNS 1145 | 7.43e-05 | 33 | 156 | 4 | CID000190902 | |
| Drug | IHC-64 | 7.43e-05 | 33 | 156 | 4 | CID000162753 | |
| Drug | 25(OH) vitamin D3 | 8.03e-05 | 150 | 156 | 7 | CID000001593 | |
| Drug | MW 1 | 8.38e-05 | 151 | 156 | 7 | CID000073965 | |
| Drug | gallopamil | 9.71e-05 | 67 | 156 | 5 | CID000001234 | |
| Drug | NP-EGTA | 1.09e-04 | 14 | 156 | 3 | CID000183793 | |
| Drug | AC1L1I1D | 1.17e-04 | 37 | 156 | 4 | CID000004381 | |
| Drug | 4-chloro-m-cresol | 1.17e-04 | 37 | 156 | 4 | CID000001732 | |
| Drug | AC1L1D8L | 1.28e-04 | 71 | 156 | 5 | CID000002241 | |
| Drug | FPL 64176 | 1.35e-04 | 15 | 156 | 3 | CID000003423 | |
| Drug | AC1L1JVU | 1.37e-04 | 72 | 156 | 5 | CID000005229 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 1.39e-04 | 3 | 156 | 2 | CID000080262 | |
| Drug | octahydromezerein | 1.39e-04 | 3 | 156 | 2 | CID000164152 | |
| Drug | flubendiamide | 1.39e-04 | 3 | 156 | 2 | CID011193251 | |
| Drug | bioresmethrin | 1.39e-04 | 3 | 156 | 2 | ctd:C002842 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.54e-07 | 3 | 159 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.54e-07 | 3 | 159 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | Familial monosomy 7 syndrome | 2.89e-05 | 2 | 159 | 2 | cv:C5681220 | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.19e-04 | 22 | 159 | 3 | C3711387 | |
| Disease | Colorectal Carcinoma | CPAMD8 MYOT ANK2 POLE BMPR1A NF1 RHPN2 SNX8 PRKCE KDM2A UGT3A2 VWA2 | 4.44e-04 | 702 | 159 | 12 | C0009402 |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 5.95e-04 | 7 | 159 | 2 | DOID:0080348 (implicated_via_orthology) | |
| Disease | bitter alcoholic beverage consumption measurement | 7.87e-04 | 133 | 159 | 5 | EFO_0010092 | |
| Disease | triglyceride change measurement, response to long-chain n-3 PUFA dietary supplementation | 7.91e-04 | 8 | 159 | 2 | EFO_0007681, EFO_0009308 | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 7.91e-04 | 8 | 159 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | metabolite measurement | FMO2 FMO3 ANK3 CES1 DNAJC16 CYP3A43 MICAL2 FBXO39 ACSM6 RAD23B | 9.59e-04 | 560 | 159 | 10 | EFO_0004725 |
| Disease | glycogen storage disease (is_implicated_in) | 1.01e-03 | 9 | 159 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | late-onset Alzheimers disease | 1.07e-03 | 292 | 159 | 7 | EFO_1001870 | |
| Disease | acute necrotizing pancreatitis (implicated_via_orthology) | 1.26e-03 | 10 | 159 | 2 | DOID:0080998 (implicated_via_orthology) | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.26e-03 | 10 | 159 | 2 | C1631597 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.27e-03 | 148 | 159 | 5 | C0279702 | |
| Disease | kidney cancer (implicated_via_orthology) | 1.54e-03 | 11 | 159 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | methionine sulfone measurement | 1.84e-03 | 12 | 159 | 2 | EFO_0800072 | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 1.84e-03 | 12 | 159 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 1.94e-03 | 163 | 159 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 2.52e-03 | 14 | 159 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | corpus callosum posterior volume measurement | 2.80e-03 | 52 | 159 | 3 | EFO_0010298 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.89e-03 | 15 | 159 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | triiodothyronine measurement | 3.29e-03 | 16 | 159 | 2 | EFO_0008392 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 3.63e-03 | 57 | 159 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | Muscle hypotonia | 3.72e-03 | 17 | 159 | 2 | C0026827 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 3.72e-03 | 17 | 159 | 2 | cv:C0270914 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.19e-03 | 195 | 159 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | disease progression measurement | 4.40e-03 | 61 | 159 | 3 | EFO_0008336 | |
| Disease | metabolonic lactone sulfate measurement | 4.65e-03 | 19 | 159 | 2 | EFO_0800659 | |
| Disease | serum IgE measurement | 5.03e-03 | 64 | 159 | 3 | EFO_0004579 | |
| Disease | exercise test | 5.14e-03 | 20 | 159 | 2 | EFO_0004328 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 5.16e-03 | 128 | 159 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 5.16e-03 | 128 | 159 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 5.16e-03 | 128 | 159 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 5.16e-03 | 128 | 159 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 5.16e-03 | 128 | 159 | 4 | C0007134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ANPEMYQELLQHKCF | 316 | Q6P461 | |
| FHTVPYMVGINKQEF | 341 | P23141 | |
| VMFYLETQQKINHLP | 536 | Q7Z569 | |
| QKDVVQLHAPRYQSM | 86 | Q9GZU0 | |
| KMLQINADPHYFTQV | 271 | Q15078 | |
| QVAHFPFKNNMSFVV | 286 | P08697 | |
| YTVNLMQKNFLPHNF | 56 | Q99965 | |
| MKPLDQDFQNFCHYQ | 81 | Q99965 | |
| HTHYVMQIVINPKDN | 141 | P35606 | |
| FEHIIYQMKNNDPNV | 136 | Q9Y3Q7 | |
| IDHNQMFQYFITVVP | 241 | Q96RQ1 | |
| NPSQYRFEHLVTQMK | 76 | Q9BX10 | |
| IGPYFEHNMKTQVEQ | 66 | P54840 | |
| VHVYMKDINDNAPKF | 1196 | Q6V0I7 | |
| YAQMNHIQVEKIEPS | 551 | Q5VV41 | |
| YQHVAAVDPEKAQQM | 431 | P51693 | |
| FHNQAIMVTKPVQEY | 746 | Q9UKA4 | |
| HYSKMPNQIATLDFN | 701 | O60306 | |
| KVSGMQAAIPYHFNI | 636 | Q96MI9 | |
| MFHAPVRKVQNYTVN | 126 | Q6IQ32 | |
| ELFPSNVYQVHMEVA | 701 | Q6IQ32 | |
| YPMVHLLQKSDNSFN | 1746 | Q7Z401 | |
| HKQYMGNRFIQVHPI | 491 | Q9NTZ6 | |
| ALNHMVQQDYFPKAL | 541 | P46060 | |
| HMNYIQVTPQEKEAI | 356 | P54727 | |
| NFYHVKNNMKIIDPD | 171 | Q13356 | |
| NLPYHQELKMVFQIQ | 56 | Q99650 | |
| HQLAMDAENNIEKYP | 26 | Q1A5X6 | |
| LSDQKNAPYQHMFRL | 541 | Q14573 | |
| NNFMLYKEDRSHVPI | 56 | P43630 | |
| PLDQNIQFHQLMGYV | 306 | Q96PH1 | |
| FTPLYMAAQENHIDV | 131 | Q01484 | |
| YQHVLAVDPEKAAQM | 511 | Q06481 | |
| YMETHNFKLPQDDLQ | 306 | Q9Y5R2 | |
| FNPVIYTMRNKEVHQ | 286 | Q9GZK7 | |
| DDFPNFMHNSKIQEY | 76 | P31513 | |
| LTQLPHFQYQAIMKE | 101 | Q3ZCV2 | |
| PFHVYKAFSENMLDQ | 1191 | Q8IV33 | |
| NTYLKQFHLAPVMDE | 356 | O60551 | |
| ANMKHPNIVQYRESF | 56 | Q96PY6 | |
| AMVAAQIPYDVQHVD | 1221 | Q2M2H8 | |
| HDPQTLEQNIMDKNY | 1271 | Q8N201 | |
| PQAFKFFMEQHVENV | 636 | O95835 | |
| NNYPMAKFVQCHFKE | 2046 | Q9UKN7 | |
| MPQEINYKEAFQHEV | 151 | Q96IM9 | |
| VQNVHMYLPTKLFQA | 711 | P46020 | |
| QVNGHKFMATYLRQP | 166 | Q02156 | |
| QDFYHAMQNIVPASQ | 651 | Q9ULI0 | |
| FNEYQAHAGPITKML | 631 | Q96MR6 | |
| IIQPDKNNYAAMVFH | 126 | Q96D96 | |
| THNMDVPNIKRNDYQ | 76 | Q9GZV4 | |
| EKMPPDYISHFQEQN | 786 | O15327 | |
| HKNEMLQFKIYDPNN | 1941 | O43451 | |
| IHYVFDIQMLPNDLN | 2026 | Q8IYD8 | |
| FIMYELATHPDVQQK | 316 | P08684 | |
| YSFAPTKLNEQIHMA | 641 | Q9P1W3 | |
| RFLVMIQEDYHSQNP | 196 | Q13946 | |
| HLEVKFMNPYNAVLT | 91 | Q8N4B4 | |
| IHVNFELMVRPNNYS | 126 | Q5T1M5 | |
| PHANMNVHYIPAEKN | 236 | Q8N5Y2 | |
| QDAAPIPNQYDKHFM | 676 | Q9Y2G8 | |
| KDLHSVMAPYFLQQR | 131 | Q6P1K2 | |
| QVYGAKFVASHPIQM | 971 | O75164 | |
| KFVASHPIQMYQVEF | 976 | O75164 | |
| FNVQVKSAQPSPHYM | 221 | Q93052 | |
| QYFHQLEKMNVKIPE | 606 | P42704 | |
| SLHDYAKIFPMNNAT | 326 | P49279 | |
| AHYDQQMGQKVQLPA | 331 | Q9H0R5 | |
| QYIAVHVVPDQLMAF | 36 | P14174 | |
| MVQAFHANIIFPNKQ | 506 | Q07864 | |
| QVEQYMSFHKLPADT | 366 | Q9P1Z3 | |
| HNEPAQEKMAYVAVA | 466 | Q9H579 | |
| PYIIDLQSMHQFRQD | 71 | Q86Y01 | |
| MEYNINVKSHPEIQF | 616 | Q86Y13 | |
| QVISVIQDHPFKMYQ | 206 | Q9BXL5 | |
| EINAANSKQPIHMVY | 226 | Q15119 | |
| MAYAREQQETNPLFH | 271 | Q3KR16 | |
| QTPMYFFLQHLALIN | 56 | Q8NGP2 | |
| TCHKFYMQIFQLPNE | 806 | Q9Y2I7 | |
| VRVMDVNDHKPEFYN | 341 | Q9BYE9 | |
| QPEYIHEQNRFQLMT | 86 | Q9C0G6 | |
| HSFNIPMQLKIYNIE | 301 | Q9Y2K7 | |
| LHEAAMQYPKQGIFS | 451 | Q9BZ29 | |
| FIMYELATHPDVQQK | 316 | Q9HB55 | |
| LYMHQLHKQQAQAEP | 711 | Q7Z3C6 | |
| KESKADAMPQHFYQN | 2506 | Q8N3K9 | |
| EQNMIHFAPNVFVLK | 1146 | Q8IZJ3 | |
| EKEPQFKFIYFNHMN | 371 | P86791 | |
| QEKQAACPFYNHEQM | 311 | A8MPP1 | |
| QQLHMFLNQYEELPY | 3616 | Q8WXX0 | |
| SLNKNHFQPYIMADI | 416 | P36894 | |
| EKEPQFKFIYFNHMN | 371 | P86790 | |
| FTPLYMAAQENHLEV | 141 | Q12955 | |
| NLYQEVMKHADPRIQ | 6 | Q9BW60 | |
| QQRLTAKEAMEHPYF | 311 | P19784 | |
| QFLNAGKHVLVEYPM | 86 | P53004 | |
| NHYDQQTAALAMEPF | 51 | Q9NPG1 | |
| QYNANHPDFPMQIEQ | 2471 | Q14204 | |
| ENNMVSLYKYIFPAH | 346 | Q99518 | |
| LQVKYQDAPAAQFMA | 81 | Q14145 | |
| HMYNFLAQPNAIVHL | 356 | Q5VZK9 | |
| EAIMHQYPNFKEEAQ | 396 | Q6SJ93 | |
| LHFYNVKSSLAQPQM | 556 | P53992 | |
| SIGNIMNNKVFYQHP | 2181 | P21817 | |
| LGDIMNNKVFYQHPN | 2146 | Q92736 | |
| NNKVFYQHPNLMRAL | 2151 | Q92736 | |
| LVNLYMNDHRPKAQA | 966 | O94851 | |
| PDHVIGNQINMFLNY | 531 | Q8N323 | |
| IQTEQSLHQPMFYFL | 51 | Q8NH55 | |
| YHPQAVFQMLNAVDT | 1266 | Q6ZUA9 | |
| SDYAPLQQFFVVMEH | 96 | Q7L099 | |
| MSQDINFEQPYEKHA | 591 | Q5TCS8 | |
| NFKHEVSVPYAMNLL | 56 | Q9Y580 | |
| RKNIAQLQPDMEAHY | 776 | Q9H5Y7 | |
| NDFVVFQEMLLHKFP | 111 | Q9Y5X2 | |
| MYHIQQVGKFKEPQA | 426 | P17252 | |
| TLVKEIVPYNMAHNA | 186 | Q13200 | |
| YHAKDPNNLFMVRLA | 751 | Q13200 | |
| NLHFPNQYEDKTTNM | 466 | Q8IVG5 | |
| LMINKYFEDHQVQQA | 266 | Q5K651 | |
| INAFQHFPEQMKLYG | 246 | Q53T94 | |
| NMHYNKANDFEVPER | 666 | Q92786 | |
| VMHANNPKYVLRNYI | 586 | Q9BVL4 | |
| LSSNPLMYLHKNQFE | 336 | Q8WXD0 | |
| NQCYFHQFMKEQPDL | 271 | Q07837 | |
| KANIVAYHDSIMNPD | 86 | Q9UBT2 | |
| DALYPNVENMHFEVQ | 801 | O15457 | |
| HQLAMDAENNIEKYP | 26 | B3KU38 | |
| QFKDPEHLYNAAMVE | 706 | Q96J65 | |
| YQQLHAAMSQAPVKE | 321 | Q8IUC4 | |
| YPQDFHNVMQLLDSQ | 356 | Q86YF9 | |
| QKVVPHVVMQYNFDF | 566 | O60287 | |
| FNYHKVLPMNTGVEA | 131 | P04181 | |
| LMFYNQTKNIVPHDQ | 196 | Q96DW6 | |
| QMKHPQQFSFVLYLG | 276 | Q495N2 | |
| VGQLFNQHPDVFYLM | 56 | Q9GZX3 | |
| ANQVFHPVMFDKCIQ | 131 | P42695 | |
| VRHDPNMKYELQLAN | 2286 | Q6P2Q9 | |
| FIPQDIMHGQYNVLQ | 386 | Q96JI7 | |
| SELHKFMPNNQLNYK | 496 | Q9UM82 | |
| AMNAHTPQFFIYKID | 981 | O94966 | |
| KQVNVTYGHMPVFQH | 176 | Q8N9K5 | |
| ALDVMKHQPYQLNAS | 961 | Q9UMS6 | |
| KPMAVAEANQYTFHL | 81 | Q2QD12 | |
| VEMHNYVPANSLQQK | 51 | Q9Y4P9 | |
| DIMNNKVFYQHPNLM | 2046 | Q15413 | |
| DDVIQFARNHPLMYN | 396 | Q13214 | |
| QLGHKVSQMAQYFEP | 1726 | Q9Y490 | |
| FVVTKGNIAQMYHAP | 111 | Q15269 | |
| QHEYVDQPKMSEVAQ | 826 | Q9H2E6 | |
| HVMVYSDPQDLFNQI | 496 | Q5GFL6 | |
| PNFDMLYNHVKQLLS | 621 | Q9HAV4 | |
| VSVHNLLPNYNTFME | 726 | P21359 | |
| VAQVPAAFYMQSVHL | 616 | P78364 | |
| VNNPLHLDYVMAAAN | 756 | P22314 | |
| HFTVMNYDPDVVLKQ | 511 | Q14166 | |
| HATFNDPVMAQQHYV | 191 | Q9UL40 | |
| VLTMAFNPDNEYHFK | 231 | Q9UPU5 | |
| QNVPKDTMDHVNEVY | 771 | Q01118 | |
| SMAKYFRNNFINPHI | 546 | Q6UXY8 | |
| QVAHMFPAKQHIQTY | 221 | Q8NA23 | |
| EIFKEMNNAFAHLPQ | 311 | Q3SY77 | |
| VDLYQFMAKDNVPFH | 546 | P56192 | |
| FQIVHKNDPDYIVMQ | 391 | O75386 | |
| FNKMNFIKTYPAHQN | 101 | Q8IWB7 | |
| MFNYERPKHFIQSQN | 1 | Q9UBF9 |